• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Catalog Number RONYX27530JX
Device Problems Activation, Positioning or Separation Problem (2906); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Thrombus (2101)
Event Date 11/26/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
During a procedure a resolute onyx coronary drug eluting stent was used to treat a moderately tortuous and calcified lesion exhibiting 75% stenosis located in the left main (lm) coronary artery, and proximal-mid lad.The device was inspected with no issues.Negative prep was performed with no issues.The lesion was pre-dilated.The device did not pass through a previously deployed stent.Resistance was not encountered while advancing the device.Excessive force was not used during delivery.After pre-dilation was performed a 2.25x38mm non-medtronic stent was implanted in the mid-distal lad.Dilation was carried out several times for proximal-mid lad using a 2.0x15mm non-medtronic balloon from 10-16atm.The resolute onyx 2.75x30mm stent was next implanted in the proximal-mid lad at 12atm.A 4.0x15mm non-medtronic balloon was then implanted in the left main trunk (lmt) ostium of lad to overlap the resolute onyx.A 4.0mm stent balloon was inflated at 6 atm in the overlapping part.Thereafter the stent balloon reached the lmt and was inflated to 20 atm.Thereafter, kissing balloon technique (kbt) was performed at lmt.An angiography was performed and showed that there were no issues and that all stents were sufficiently adhered to the vessel wall.The procedure was completed.It was reported that 7 days post procedure the patient presented with chest pain.A coronary angiography (cag) was performed showing an in stent thrombosis in the overlapping part of the stent.The thrombosis was treated by aspiration.Ivus was performed and showed that there was insufficient post dilation and that the overlapping portion of the stent was not sufficiently expanded.Post dilation was performed several times from 16atm to 23atm with a 2.5x15mm nc balloon, timi 3 flow developed, and then, the dilation was performed in lmt with a 4.0x15mm nc balloon.Post dilation was also performed in the proximal-mid lad using 3.0x15mm nc balloon at 23atm.Ivus was performed and showed that the stent expanded well.An angiography was performed with no issues noted and the procedure was completed.The patient is reported to be alive.No further patient injury has been reported.
 
Manufacturer Narrative
Correction: a 4.0 x 15mm non-medtronic stent was then implanted in the left main trunk (lmt) ostium of lad to overlap the resolute onyx.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
The device was being used to treat a lesion exhibiting 90% stenosis.The patient was treated with dapt post implantation.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE ONYX RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8154718
MDR Text Key130033746
Report Number9612164-2018-03575
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/12/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/24/2020
Device Catalogue NumberRONYX27530JX
Device Lot Number0008962808
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/19/2019
Date Device Manufactured01/24/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
Patient Weight60
-
-